According to a new scientific publication, genetically engineered mosquitoes produced by Oxitec (Intrexon) have escaped human control after trials in Brazil. They are now spreading in the environment. The yellow fever mosquitos (Aedes aegypti) are genetically engineered to make it impossible for their offspring to survive. After release they were supposed to mate with female mosquitos of the species which are transmitting infectious diseases, such as Dengue fever, to diminish the natural populations.
GeneTip project publishes initial results
19 August 2019 / The GeneTip research project was a joint enterprise carried out from 2017 until 2019 by the Universities of Bremen and Vechta, the University of Natural Resources and Life Sciences, Vienna and Testbiotech, Munich. The researchers focussed mainly on risks associated with the uncontrolled spread into the environment of newly designed genetically engineered organisms. In particular, the project examined plants and animals with a so-called gene-drive.
New techniques for genetic engineering not as precise as claimed
6 August 2019 / According to research undertaken by experts at the US Food and Drug Administration (FDA), gene-editing errors in the genome of the animals are, in many cases, often being overlooked. This was the finding from the FDA genome analyses of cattle genetically engineered not to grow horns. The animals were genetically engineered by Recombinetics; the company also filed a patent on the genetically engineered cattle. The cattle have for some years been held up and presented as a positive example for the application of new genetic engineering techniques.
Outgoing EU Commission approves controversial applications for import before handing over
1 August 2019 / The EU Commission has given market approval to seven new genetically engineered (GE) plants. These include approvals for the import of GE maize, cotton and soybeans that are herbicide-resistant and produce insecticidal toxins. In March 2019, Testbiotech, together with around 40 organisations, called on the EU Commission to halt the approval processes because health risks from consuming products derived from the plants were not sufficiently assessed.